(Q42256599)

English

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.

scientific article published on 11 November 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

post-transplant lymphoproliferative disorder

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Christopher P Fox

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ronjon Chakraverty

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Charles Craddock

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

D Burns

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

K S Peggs

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C M Harvey

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Natarajan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

D I Marks

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

B Jackson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Chakupurakal

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Dennis

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Z Lim

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Cook

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

B Carpenter

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A R Pettitt

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Mathew

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

L Connelly-Smith

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J A L Yin

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Viskaduraki

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

B E Shaw

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Brookes

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Chaganti

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

0 references

publication date

11 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

280-286

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.170

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-transplant lymphoproliferative disease following reduced intensity conditioning transplants incorporating alemtuzumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post transplant lymphoproliferative disorders following reduced intensity conditioning with in vivo T cell depletion

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor T cells to treat EBV-associated lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CAMPATH-1 antibodies in stem-cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prompt versus preemptive intervention for EBV lymphoproliferative disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epstein-Barr virus lymphoproliferation after bone marrow transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of CAMPATH-1H in BMT patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24212561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2013.170

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24212561%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42256599&oldid=2205172165"